Acme Therapeutics (I) Private Limited - Company Profile

It is a pharma private limited company based in Panchkula, Haryana, India, established in 2001.
2001 Panchkula, Haryana, India Active
Last Updated:
Access Report
About Acme Therapeutics (I) Private Limited

Acme Therapeutics (I) Private Limited, a active private limited company, was established on 14 March 2001 in Panchkula, Haryana, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U24232HR2001PTC093261. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹1.80 M and a paid-up capital of ₹1.62 M.

Formerly known as Acme Therapeutics Private Limited, Acme Pharmaceuticals Private Limited. It upholds a compliant status. Employing 302 professional, Its leadership includes Banshidhar Kanhaiyalal (Director), Gopal Krishna (Director), Sanjay Kumar (Director). Past directors included Binod Kumar Agarwal, Rajesh Kumar Jain, Murlidhar Kanhaiyalal. It holds ₹4.25 Cr open charges and ₹1.60 Cr settled loans. Its latest AGM occurred on 27 September 2025, with the balance sheet filed on 31 March 2025. It is based at Flat No 1601, Tower 7A Suncity Parikrama, Sector 20, Panchkula, Haryana, 134109.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24232HR2001PTC093261

  • Registration Number

    093261

  • Incorporation Date

    14 March 2001

  • Authorized Capital

    ₹1.80 M

  • Paid-Up Capital

    ₹1.62 M

  • ROC Code

    Roc Delhi

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 1.80 M
  • Paid Up Capital ₹ 1.62 M
  • Company Age 24 Year, 11 Months
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 4.25 Cr
  • Satisfied Charges ₹ 1.60 Cr
  • Revenue Growth **** 4.01%
  • Profit Growth **** -0.14%
  • Ebitda **** -36.38%
  • Net Worth 13.16%
  • Total Assets **** 2.26%
Company report

Acme Therapeutics (I) Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Acme Therapeutics (I) Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Acme Therapeutics (I) Private Limited?
Current Directors
Name Designation Appointment Date Status
Banshidhar Kanhaiyalal Director 14 Mar 2001 Current
Gopal Krishna Director 01 May 2002 Current
Sanjay Kumar Director 21 Oct 2019 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 19 Oct 2019 Past
Pramod Abcsdd Director 23 Mar 2009 Past
Pramod Abcsdd Director 16 Mar 2009 Past
Pramod Abcsdd Director 01 Dec 2008 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Acme Therapeutics (I).

Acme Therapeutics (I) Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 4.01% increase. The company also saw a slight decrease in profitability, with a 0.14% decrease in profit. The company's net worth Soared by an impressive increase of 13.16%.

Acme Therapeutics (I) revenue growth over time
Acme Therapeutics (I) profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 4.01%
*******
*******
*******
*******
Revenue from Operations
*******
 3.98%
*******
*******
*******
*******
Total Assets
*******
 2.26%
*******
*******
*******
*******
Profit or Loss
*******
 -0.14%
*******
*******
*******
*******
Net Worth
*******
 13.16%
*******
*******
*******
*******
EBITDA
*******
 -36.38%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Acme Therapeutics (I)?

In 2023, Acme Therapeutics (I) had a promoter holding of 95.69% and a public holding of 4.31%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹42,500,000.00

Satisfied Charges

₹16,025,000.00

Charges Breakdown by Lending Institutions
  • Hdfc Bank Limited : 2.75 Cr
  • Others : 1.50 Cr
Latest Charge Details
Date Lender Amount Status
27 Jan 2025 Hdfc Bank Limited ₹2.75 Cr Open
13 Feb 2024 Others ₹1.50 Cr Open
20 Mar 2020 Others ₹8.33 M Satisfied
10 Dec 2015 Kotak Mahindra Bank Limited ₹4.20 M Satisfied
03 Jun 2004 Punjab National Bank ₹3.50 M Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Acme Therapeutics (I)?

Acme Therapeutics (I) has a workforce of 302 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Acme Therapeutics (I), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Acme Therapeutics (I)'s trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Acme Therapeutics (I)
Recent Activity within the Organization
  • Charges

    The activity A charge registered on 20 Mar 2020 via Charge ID 100341247 with Others was fully satisfied on 19 Nov 2025. was completed.

  • Annual General Meeting

    The activity Acme Therapeutics (I) Private Limited last Annual general meeting of members was held on 27 Sep 2025 as per latest MCA records. was completed.

  • Balance Sheet

    Progress on Acme Therapeutics (I) Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi. was documented.

  • Charges

    Progress on A charge with Hdfc Bank Limited amounted to Rs. 27.50 M with Charge ID 101049295 was registered on 27 Jan 2025. was documented.

  • Charges

    A charge with Others amounted to Rs. 15.00 M with Charge ID 100875794 was registered on 13 Feb 2024. was recorded as a recent event.

  • Charges

    The activity A charge with Others amounted to Rs. 8.33 M with Charge ID 100341247 was registered on 20 Mar 2020. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Acme Therapeutics (I) Private Limited?

The CIN of Acme Therapeutics (I) Private Limited is U24232HR2001PTC093261.

Where is Acme Therapeutics (I) Private Limited headquartered?

Acme Therapeutics (I) Private Limited is headquartered at Flat No 1601, Tower 7A Suncity Parikrama, Sector 20, Panchkula, Haryana, 134109.

When was Acme Therapeutics (I) Private Limited incorporated?

Acme Therapeutics (I) Private Limited was incorporated on 14 March 2001.

Who are the current directors of Acme Therapeutics (I) Private Limited?

The current directors of Acme Therapeutics (I) Private Limited are

What is the primary industry of Acme Therapeutics (I) Private Limited?

The primary industry of Acme Therapeutics (I) Private Limited is Trade.

Is Acme Therapeutics (I) Private Limited a listed company?

Acme Therapeutics (I) Private Limited is unlisted.

What is the capital structure of Acme Therapeutics (I) Private Limited?

The authorized capital of Acme Therapeutics (I) Private Limited is ₹1.80 M, and the paid-up capital is ₹1.62 M.

What is the compliance status of Acme Therapeutics (I) Private Limited?

The compliance status of Acme Therapeutics (I) Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available